Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...

Supreme Court set to consider cert. petition on generic drug use of “skinny labels” to avoid infringing method of use patents. Court expected to consider cert. petition during court conference on May ...

The Alabama Supreme Court recently reaffirmed that patients are allowed to sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side ...

WASHINGTON -- Every medication given in the hospital soon will carry a label with a supermarket-style bar code that can be matched to patients and help ensure they get the right dose of the right drug ...